ClarityRx Clinical Skin Care, Inc.

ClarityRx Clinical Skin Care, Inc. specializes in medical-grade, plant-powered skincare products. They are dedicated to providing effective solutions addressing various skin concerns through a range of targeted treatments and moisturizers. Founded in 2003 and headquartered in the US, ClarityRx Clinical Skin Care, Inc.

is a skincare company that focuses on innovative, results-driven products. The company was acquired by Topix Pharmaceuticals, Inc. in February 2019, part of a strategic move to enhance its market presence. The founder, Karla Keene, has a background in the beauty industry and oversees the company's operations as CEO.

ClarityRx offers a variety of medical-grade skincare products, including moisturizers, serums, and treatments aimed at improving skin health. Their noteworthy products, such as the Better With Age™ Multi-Peptide Moisturizer and Better With Age™ Renewing Serum, utilize advanced ingredients like peptides and Bakuchiol to combat aging signs and enhance hydration. The company serves direct consumers and licensed professionals in skincare, actively distributing its products across North America and select international markets. ClarityRx operates on a direct-to-consumer basis, supplemented by partnerships with licensed professionals and estheticians.

Revenue is generated through product sales and potential subscription services, with flagship products priced in the premium range; the Better With Age™ Multi-Peptide Moisturizer starts at USD 28, while the Better With Age™ Renewing Serum begins at USD 39. The company has implemented a rewards program to foster customer loyalty and repeat purchases. Following its acquisition by Topix Pharmaceuticals, Inc. in February 2019, ClarityRx plans to expand its product line with innovative new offerings aimed at addressing additional skin concerns.

The company is also targeting expansion into new international markets, enhancing its distribution footprint. Funding from the acquisition is expected to support these initiatives, allowing ClarityRx to leverage resources for product development and market penetration.